Vaccine rollout
As of Sunday 7 November,
2,289,946 COVID-19 vaccine doses have been delivered in South Australia and
36,707,411 COVID-19 vaccine doses had been administered in Australia.
Vaccine facts
97.5% of the reported COVID-19 cases in NSW are in unvaccinated people (March to September 2021).
COVID-19 vaccines were developed quickly due to years of research on related viruses, faster ways to manufacture, huge funding and multiple trials in parallel.
Vaccines do not have late onset side effects, and COVID-19 vaccines are no different.
COVID-19 vaccines are close to 90% effective in reducing symptoms and preventing hospitalisation from the Delta strain.
Seat belts reduce the risk of serious injury or death by 50%, COVID-19 vaccines reduce your risk of serious illness or death by close to 90%.
COVID-19 vaccines have been tested, reviewed and approved in exactly the same way as all other vaccines.
Mobile, pop-up and walk in vaccination clinics
SA Health has launched a new fleet of mobile COVID-19 vaccination vans across metropolitan and regional South Australia. These additional mobile vans will strengthen our outreach in pockets of the community that have lower vaccination rates.
Mobile and pop-up clinics are visiting areas across metro and regional South Australia. Visit
sahealth.sa.gov.au/covidvaccine to find a pop-up clinic near you.
All SA Health vaccination clinics (with the exception of Limestone Coast Local Health Network) now offer walk-in appointments, making it easier to get vaccinated. For more information, visit
sahealth.sa.gov.au/covidvaccine.
Walk-in appointments are limited and you may need to wait. Priority will be given to people with existing bookings. The most convenient option is to book your preferred date and time online at
https://covid-vaccine.healthdirect.gov.au/eligibility.
Second dose
Australian Technical Advisory Group on Immuniation (ATAGI) recommends that the same COVID-19 vaccine brand should be used for the two doses of the primary course of vaccination.
However, as the supply of vaccines, particularly mRNA vaccines, is no longer constrained, ATAGI advises an alternative vaccine brand can be given if first dose recipients are unable to receive a second dose of the same brand or do not want to have a second dose of the same brand.
If you had AstraZeneca for your first dose, please have your second dose 8 to 12 weeks after your first dose.
If you do not wish to have another dose of AstraZeneca, you may have a Pfizer or Moderna vaccine at least 4-12 weeks after your first dose of AstraZeneca.
Third dose of COVID-19 vaccine for people who are severely immunocompromised
Currently, the Australian Technical Advisory Group on Immunisation (ATAGI) recommend that people who are severely immunocompromised aged 12 and over receive a third dose of a COVID-19 vaccine.
This is to increase the level of immunity for
severely immunocompromised people to as close as possible to the general population.
The Pfizer or Moderna COVID-19 vaccines are preferred for a third dose for people who are severely immunocompromised. The AstraZeneca COVID-19 vaccine can be used for the third dose for individuals who received AstraZeneca for their first two doses if there are no contraindications or precautions for use, or if a significant adverse reaction occurred after receiving the Pfizer or Moderna COVID-19 vaccines.
The recommended interval for the third dose is 2 to 6 months after the second dose of vaccine. A minimum interval of 4 weeks may be considered in exceptional circumstances. People who have received a second dose more than 6 months ago should receive a third dose as soon as possible.
Click here for more information.
Booster vaccines
The Therapeutic Goods Administration (TGA) has provisionally approved a booster dose of the Pfizer vaccine for individuals 18 years and older.
The provisional approval means that individuals aged 18 years and older may receive a booster (third dose), at least six months after the completion of a COVID-19 vaccine primary series. This primary series can be of any of the COVID-19 vaccines registered for use in Australia, although data on the use of COMIRNATY as a booster with other COVID-19 vaccines is more limited.
COVID-19 vaccine booster doses are recommended to maintain immunity against the virus.
All people aged 18+ years who have had their second dose of a COVID-19 vaccine at least six months ago are eligible for a booster dose.
Anyone can receive their booster dose at participating GPs, pharmacies, and Respiratory Clinics (online bookings open 8 November).
From Wednesday 1 December, anyone due will be able to get their booster dose at SA Health vaccination clinics.
SA Health vaccination clinics will continue to focus on delivering first and second dose vaccines to the community.
COVID-Ready Plan
South Australia’s
COVID-Ready Plan outlines the safe easing of restrictions and how COVID-19 will be managed in South Australia.
For more information visit
www.covid-19.sa.gov.au/response